merck glp-1 drug New Study Explores How Analog Administration Affects Running in Mice Novo's Wegovy becomes first GLP-1

Type 2 diabetes and obesity dramatically increase the risk of dementia by up to 60%, accelerating amyloid pathology, cerebrovascular damage, and insulin resistance in the brain, sometimes described as type 3 diabetes [1]

Navigating claims like these starts with staying informed, questioning bold promises, and focusing on evidence-based approaches that truly support your health.

About Hansoh Pharmaceutical Hansoh Pharmaceutical Group is one of Chinas leading biopharmaceutical companies, focused on the discovery, development, and commercialization of novel therapies in oncology, central nervous system diseases, and metabolic diseases

In light of the close etiopathogenetic correlation with metabolic syndrome, NAFLD has been recently redefined as metabolic dysfunction-associated fatty liver disease (MAFLD) [3]

After stopping tirzepatide, patients typically regain about two-thirds of lost weight within a year

First global approval